2nd GxP Cloud Compliance Summit | Virtual | July 14-15

Memo

Establish Robust Documentation Practices to Maintain CFR 11 Compliance, Accurately Assess Data Security Risks for Migrating to Cloud Infrastructure and Select the Right Partner to Ensure Sustained Continuous Compliance Free to Attend for Drug Developers, Medical Device, CRO and CMO* Nothing is more important in the pharmaceutical and life sciences industries than patient safety and meeting regulations. This past year and the global disruption have highlighted how life sciences organizations need to respond to radical shifts through digitization. The 2nd GxP Cloud Compliance Summit will return to discuss the next steps following initial feasibility study and implementation – designed to help you achieve GxP regulated security, privacy, transparency and compliance at any scale when migrating to the cloud. With 18 trailblazing stories from AbbVie, Orchard Therapeutics, AWS, USDM, Chef/Progress, we will share practical takeaways from CFR21 part 11 to mapping out data migration to selecting the right cloud providers. Across 2 days, you will gain the tools to streamline processes, facilitate on demand scalability, increase efficiency and reduce costs. This is the only dedicated industry-led meeting focused on GxP cloud adoption in the life sciences industry, join us this July to learn how to overcome the barriers of GxP cloud compliance, increase knowledge for data-powered business and empower collaboration between your organization and platform partners – providing a much more efficient operation and effective infrastructure to support your research and clinical activities. *Free Pass for Industry Practitioners: Drug Developers, Medical Device, CROs, CMOs and Research InstitutionsEligibility of free pass is subject to the organizer’s approval Date and Time: On Wednesday July 14, 2021 at 9:00 am (ends Thursday July 15, 2021 at 5:00 pm) Price: Free: USD 0.00 URL: Tickets: https://go.evvnt.com/781961-2?pid=5569 Speakers: Victor Huynh, Executive Director, Information Security and Risk Management, AbbVie, Dandan Xu, Chief Scientific Officer, SolveBio, Rimesh Gor, Associate Director, IT Business Relationship Management, Orchard Therapeutics, Octavian Boca, Principal, Massachusetts Institute of Technology, David Caplan, Chief Technology Officer, SolveBio, Anca Mihaescu, Associate Director, IT Computer Systems Validation, Jazz Pharmaceuticals Inc, Michael Redmond, Sr. Consultant and Sr. Auditor, Cyber/ Information, Security and Risk Management, Redmond Worldwide, Julia Cope, Director, Science Operations and Quality, Cosmos ID, Laur Oltean, Senior Computer Systems Validation Specialist, Engineering, IT, Lonza, Calvin Kim, Director, Quality Assurance, Digital Good Practice and Compliance Management, Bayer, Les Jordan, Chief Product and Strategy Officer, MobileSmith Health, Cory Brown, Senior Director, IT and Head of GxP Digital, Tmunity Therapeutics Inc., Murali Mani, Chief Compliance Officer, Sema4, Guru Gurushankar, Worldwide Lead, Medical Devices, Amazon Web Services, Stepheni Norton, Director, Product Management, USDM Life Sciences, John Petrakis, VP, Cloud Assurance, USDM Life Sciences